60 Degrees Pharmaceuticals, Inc.

US$0.59As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SXTPHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (87.49%)
Div yield —
ROE (332.85%)
Biotechnology
Beta (5Y) 2.47
PE TTM —
TSR TTM (89.06%)
Mkt cap US$2.092M
ROIC (207.72%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.572
(3.86%)
(48.05%)
Hold 10|3|7|8|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
42.52%
37.68%
28.94%
20.88%
Revenue$M
0.125
0.124
0.125
0.128
12.13%
10.37%
10.45%
8.31%
Peers (US$2.092M)
Cap (US$)
PE
2.112M
—
1.936M
—
Capital
TTM
5Y
10Y
Leveragex
1.508
0.245
0.176
EBIT/Intx
0.761
0.690
0.730
Own earn%
58.66
(191.53)
(134.89)
Sh yield%
24.13
40.66
37.72
Owners
Insiders/Inst%
13.00
32.60
Short interest%
4.77
SBC / revenue%
1.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
3